{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T03:11:47Z","timestamp":1789269107967,"version":"build-2803163510"},"reference-count":39,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2005,6,28]],"date-time":"2005-06-28T00:00:00Z","timestamp":1119916800000},"content-version":"vor","delay-in-days":119,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplant Infectious Dis"],"published-print":{"date-parts":[[2005,3]]},"abstract":"<jats:p><jats:bold>Abstract: <\/jats:bold> We report on bloodstream infection (BSI) rates, risk factors, and outcome in a cohort of 298 adult and pediatric hematopoietic stem cell transplantation (HSCT) recipients at Memorial Sloan\u2010Kettering Hospital from September 1999 through June 2003.<\/jats:p><jats:p><jats:bold>Methods. <\/jats:bold> Prospective surveillance study. BSI rates are reported per 10,000 HSCT days. Date of engraftment is defined as the first of at least 3 consecutive dates of absolute neutrophil count &gt;500\/mm<jats:sup>3<\/jats:sup> after stem cell infusion. BSI severity grades: severe (intravenous antibiotics), life threatening (sepsis), or fatal (caused or contributed to death).<\/jats:p><jats:p><jats:bold>Results. <\/jats:bold> The incidence of pre\u2010 and post\u2010engraftment BSI was 22% and 19.5%, respectively. Pre\u2010engraftment highest rates were observed for viridans streptococci (58), Enterobacteriaceae (39), and <jats:italic>Enterococcus faecium<\/jats:italic> (34). Post\u2010engraftment rates ranged from 0.2 to 2.9 without any predominant pathogen. In multivariate analyses, pre\u2010engraftment BSI was associated with diagnosis of chronic myelogenous leukemia, age &gt;18 years and peripheral blood stem cell graft; post\u2010engraftment BSI was associated with acute graft\u2010versus\u2010host disease, neutropenia, and liver or kidney dysfunction. Attributable mortality was 12.5% and 1.7% for pre\u2010 and post\u2010engraftment BSI, respectively. BSI fatality rates were 24% for viridans streptococci, 8% for <jats:italic>E. faecium<\/jats:italic>, 11% for <jats:italic>Staphylococcus aureus<\/jats:italic>, and 67% for <jats:italic>Candida<\/jats:italic>.<\/jats:p><jats:p><jats:bold>Conclusions. <\/jats:bold> Pre\u2010engraftment BSI, especially by viridans streptococci and <jats:italic>E. faecium<\/jats:italic>, was associated with substantial attributable mortality. Post\u2010engraftment BSI was a marker of post\u2010transplant complications and rarely the primary cause of death.<\/jats:p>","DOI":"10.1111\/j.1399-3062.2005.00088.x","type":"journal-article","created":{"date-parts":[[2005,6,28]],"date-time":"2005-06-28T16:56:46Z","timestamp":1119977806000},"page":"11-17","source":"Crossref","is-referenced-by-count":151,"title":["Pre\u2010 and post\u2010engraftment bloodstream infection rates and associated mortality in allogeneic hematopoietic stem cell transplant recipients"],"prefix":"10.1111","volume":"7","author":[{"given":"N.G.","family":"Almyroudis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Fuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Jakubowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Sepkowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Jaffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.N.","family":"Small","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.E.","family":"Kiehn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Pamer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.A.","family":"Papanicolaou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,6,28]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/0-306-47527-8_16"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1086\/646750"},{"key":"e_1_2_5_4_2","first-page":"618","volume-title":"Hospital Epidemiology and Infection Control","author":"Hughes W","year":"1996"},{"key":"e_1_2_5_5_2","first-page":"2633","volume-title":"Cancer Medicine","author":"Rolston KVI","year":"2003"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1086\/374339"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0277-5379(90)90079-9"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-119-7_Part_1-199310010-00006"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1086\/322604"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1086\/501942"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1701404"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01229.x"},{"key":"e_1_2_5_13_2","first-page":"1625","article-title":"Prevention of peritransplantation viridans streptococcal bacteremia with early vancomycin administration","volume":"39","author":"Jaffe D","year":"2004","journal-title":"a single-center observational cohort study"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1086\/313456"},{"key":"e_1_2_5_15_2","first-page":"756","article-title":"Outbreak of Stenotrophomonas maltophilia bacteremia among patients undergoing bone marrow transplantation","volume":"20","author":"Klausner J","year":"1999","journal-title":"association with faulty replacement of handwashing soap"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1700621"},{"key":"e_1_2_5_17_2","unstructured":"SmallT BouladF PapadopoulosE et al. Incidence and outcome of vancomycin\u2010resistant enterococcal bacteremia following allogeneic hematopoietic stem cell transplant (HSCT). In: Program and Abstracts of the 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) San Diego California September 17\u201330 2002: 325 [Abstract K\u20101226]."},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)10006-X"},{"key":"e_1_2_5_19_2","first-page":"325","article-title":"Development, testing, and application of the oral assessment guide","volume":"15","author":"Eilers J","year":"1988","journal-title":"Oncol Nurs Forum"},{"key":"e_1_2_5_20_2","first-page":"1083","article-title":"T\u2010cell\u2010depleted allogeneic bone marrow transplantation as postremission therapy for acute myelogenous leukemia","volume":"91","author":"Papadopoulos E","year":"1998","journal-title":"freedom from relapse in the absence of graft-versus-host disease"},{"key":"e_1_2_5_21_2","unstructured":"MeierE AlmyroudisN JaffeD SmallT SepkowitzK PapanicolaouG.Fever after allogeneic HSCT: correlation with infection engraftment and outcome. In: Program and Abstracts of the 41st Annual Meeting of the Infectious Diseases Society of America (IDSA) Chicago September 14\u201317 2003 [Abstract 332]."},{"key":"e_1_2_5_22_2","first-page":"303","article-title":"Gram\u2010negative bacteremia (GNB) after 428 unrelated donor bone marrow transplants (UD\u2010BMT)","volume":"33","author":"Mitchell A","year":"2004","journal-title":"risk factors, prophylaxis, therapy and outcome"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19980601)82:11<2275::AID-CNCR25>3.0.CO;2-Q"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(84)92530-3"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(84)92259-1"},{"key":"e_1_2_5_26_2","first-page":"256","article-title":"Bacteremia due to viridans streptococci in neutropenic patients","volume":"97","author":"Bochud PY","year":"1994","journal-title":"a review"},{"key":"e_1_2_5_27_2","first-page":"1201","article-title":"Septicemia and shock syndrome due to viridans streptococci","volume":"14","author":"Elting L","year":"1992","journal-title":"a case\u2013control study of predisposing factors"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830420405"},{"key":"e_1_2_5_29_2","first-page":"387","article-title":"The clinical spectrum of infections with viridans streptococci in bone marrow transplant patients","volume":"5","author":"Villablanca JG","year":"1990","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_5_30_2","first-page":"1169","article-title":"Bacteremia due to viridans streptococci that are highly resistant to penicillin","volume":"20","author":"Carratala J","year":"1995","journal-title":"increase among neutropenic patients with cancer"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-60443-0_11"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198810203191604"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1086\/339215"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1086\/376637"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199203263261301"},{"key":"e_1_2_5_36_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/171.6.1545"},{"key":"e_1_2_5_37_2","first-page":"331","article-title":"Randomized placebo\u2010controlled trial of fluconazole prophylaxis for neutropenic cancer patients","volume":"28","author":"Rotstein C","year":"1999","journal-title":"benefit based on purpose and intensity of cytotoxic therapy. The Canadian Fluconazole Prophylaxis Study Group"},{"key":"e_1_2_5_38_2","first-page":"309","article-title":"Candidemia in allogeneic blood and marrow transplant recipients","volume":"181","author":"Marr K","year":"2000","journal-title":"evolution of risk factors after the adoption of prophylactic fluconazole"},{"key":"e_1_2_5_39_2","first-page":"2055","article-title":"Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis\u2010related death in allogeneic marrow transplant recipients","volume":"96","author":"Marr K","year":"2000","journal-title":"long-term follow-up of a randomized, placebo-controlled trial"},{"key":"e_1_2_5_40_2","doi-asserted-by":"publisher","DOI":"10.1086\/378305"}],"container-title":["Transplant Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-3062.2005.00088.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-3062.2005.00088.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T18:11:48Z","timestamp":1696875108000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-3062.2005.00088.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["10.1111\/j.1399-3062.2005.00088.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-3062.2005.00088.x","archive":["Portico"],"relation":{},"ISSN":["1398-2273","1399-3062"],"issn-type":[{"value":"1398-2273","type":"print"},{"value":"1399-3062","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,3]]}}}